Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Safety Trial of STING-dependent Activators (STAVs) and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias

NCT05321940 is registered in ClinicalTrials.gov with Juan C. Ramos, MD as lead sponsor.

NCT NCT05321940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05321940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Safety Trial of STING-dependent Activators (STAVs) and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias
Lead sponsor
Juan C. Ramos, MD
Phase
Phase 1
Overall status
Withdrawn
Start date
November 30, 2023
Completion date
November 30, 2026
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, acute myelogenous leukemia, adult t-cell leukemia/lymphoma, refractory leukemia, relapsed leukemia